Remove Business Development Remove Genetic Disease Remove Genomics
article thumbnail

CAMP4’s funding influx paves the way for tapping regulatory RNA to treat urea cycle disorders

Pharmaceutical Technology

According to Bumcrot, regRNAs are “RNAs that arise out of the non-coding genome”. In order to find the specific RNA sequences for a genetic disease, the biotech is using an AI- and machine learning-based approach. Their platform identifies which regRNAs control the specific gene of interest. Future Possibilities.

RNA 245
article thumbnail

EdiGene Expands Management Team by Appointment of Head of US Subsidiary Dr. Bo Zhang and Head of Business Development Dr. Kehua Fan

The Pharma Data

.–( BUSINESS WIRE )– EdiGene, Inc. which develops genome editing technologies to accelerate drug discovery and develop novel therapeutics for a broad range of diseases, today announced the appointment of Bo Zhang, Ph.D., as Head of Business Development. He received his B.S.